Targeting brain protein could halt progression of Alzheimer's

A protein that stimulates the brain to wake up could hold the key to preventative Alzheimer's treatments, an animal study suggests.

Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)
Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)

A mouse-model study conducted by US researchers suggests that targeting orexin, a neurotransmitter that helps rouse the brain from sleep, could help prevent Alzheimer’s disease in patients who have problems sleeping.

Sleep loss is known to contribute to the growth of brain plaques, early signs of Alzheimer’s disease.

They accumulate in the brain ahead of the onset of the more severe symptoms, such as memory loss. Scientists hope that by slowing or stopping this build-up, they can put a halt on the disease.

In the latest study, published in the Journal of Experimental Medicine, researchers bred genetically-modified mice lacking the gene for producing orexin with those predisposed to developing brain plaques.

Brain plaques halved

The offspring slept for longer and developed only half as many brain plaques as their predisposed parents who had the orexin protein, suggesting that higher levels of the neurotransmitter contribute to producing more brain plaques.

When the scientists reversed the experiment, and looked at mice with artificially increased orexin levels, the mice stayed awake longer and developed more Alzheimer's-like plaques.

Lead author Dr David Holtzman said: ‘This indicates we should be looking hard at orexin as a potential target for preventing Alzheimer’s disease.

‘Blocking orexin to increase sleep in patients with sleep abnormalities, or perhaps even to improve sleep efficiency in healthy people, may be a way to reduce the risk of Alzheimer's. This is important to explore further.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Almost 4,000 GPs rejoin GMC register as COVID-19 deaths surge

Almost 4,000 GPs rejoin GMC register as COVID-19 deaths surge

Around 3,800 GPs have rejoined the medical register barely a week after the government...

Prime minister Boris Johnson and health secretary Matt Hancock infected with COVID-19

Prime minister Boris Johnson and health secretary Matt Hancock infected with COVID-19

Prime minister Boris Johnson and health and social care secretary Matt Hancock are...

'Lovely' Essex GP feared to be first UK doctor to die from COVID-19

'Lovely' Essex GP feared to be first UK doctor to die from COVID-19

An Essex GP is feared to have become the first UK doctor to die after being infected...

How PCNs are adapting to the COVID-19 pandemic

How PCNs are adapting to the COVID-19 pandemic

Primary care networks (PCNs) are hosting virtual training sessions and re-writing...

Guidance updated for pregnant healthcare staff in coronavirus outbreak

Guidance updated for pregnant healthcare staff in coronavirus outbreak

All GPs who are pregnant should have the choice to stop work in patient-facing roles...

More than 550 GPs sign up within 24 hours to support NHS111

More than 550 GPs sign up within 24 hours to support NHS111

More than 550 GPs have signed up within 24 hours to take calls for NHS 111 as the...